Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

PharmaCyte Biotech (PMCB) Interest Coverage Ratio (2016 - 2022)

PharmaCyte Biotech (PMCB) has disclosed Interest Coverage Ratio for 11 consecutive years, with 430.26 as the latest value for Q3 2022.

  • Quarterly Interest Coverage Ratio rose 32.73% to 430.26 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was 1652.71 through Apr 2023, up 38.21% year-over-year, with the annual reading at 8628.71 for FY2022, 182.94% down from the prior year.
  • Interest Coverage Ratio for Q3 2022 was 430.26 at PharmaCyte Biotech, up from 23924.83 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 430.26 in Q3 2022, with the low at 23924.83 in Q4 2021.
  • Average Interest Coverage Ratio over 3 years is 4766.36, with a median of 1655.39 recorded in 2020.
  • Peak annual rise in Interest Coverage Ratio hit 71.85% in 2021, while the deepest fall reached 1605.83% in 2021.
  • Over 3 years, Interest Coverage Ratio stood at 1402.53 in 2020, then plummeted by 1605.83% to 23924.83 in 2021, then soared by 98.2% to 430.26 in 2022.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 430.26, 23924.83, and 639.59 for Q3 2022, Q4 2021, and Q3 2021 respectively.